325 related articles for article (PubMed ID: 30172754)
1. Matrix metalloproteinases in pro-atherosclerotic arterial remodeling.
Myasoedova VA; Chistiakov DA; Grechko AV; Orekhov AN
J Mol Cell Cardiol; 2018 Oct; 123():159-167. PubMed ID: 30172754
[TBL] [Abstract][Full Text] [Related]
2. [Matrix metalloproteinases and atherosclerosis].
Fic P; Zakrocka I; Kurzepa J; Stepulak A
Postepy Hig Med Dosw (Online); 2011 Jan; 65():16-27. PubMed ID: 21357991
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
[TBL] [Abstract][Full Text] [Related]
4. Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability.
Ruddy JM; Ikonomidis JS; Jones JA
J Vasc Res; 2016; 53(1-2):1-16. PubMed ID: 27327039
[TBL] [Abstract][Full Text] [Related]
5. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
[TBL] [Abstract][Full Text] [Related]
6. Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability.
Olejarz W; Łacheta D; Kubiak-Tomaszewska G
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486345
[TBL] [Abstract][Full Text] [Related]
7. The role of matrix metalloproteinases in atherothrombosis.
Ketelhuth DF; Bäck M
Curr Atheroscler Rep; 2011 Apr; 13(2):162-9. PubMed ID: 21271310
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the Involvement of Matrix-Degrading Metalloproteinases (MMPs) in Atherosclerosis.
Brown BA; Williams H; George SJ
Prog Mol Biol Transl Sci; 2017; 147():197-237. PubMed ID: 28413029
[TBL] [Abstract][Full Text] [Related]
9. The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques.
Rai V; Agrawal DK
Can J Physiol Pharmacol; 2017 Oct; 95(10):1245-1253. PubMed ID: 28746820
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
Johnson JL
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.
Galis ZS; Khatri JJ
Circ Res; 2002 Feb; 90(3):251-62. PubMed ID: 11861412
[TBL] [Abstract][Full Text] [Related]
12. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
Wang X; Khalil RA
Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
[TBL] [Abstract][Full Text] [Related]
14. Vascular extracellular matrix in atherosclerosis.
Chistiakov DA; Sobenin IA; Orekhov AN
Cardiol Rev; 2013; 21(6):270-88. PubMed ID: 23422022
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms.
Vacek TP; Rehman S; Neamtu D; Yu S; Givimani S; Tyagi SC
Vasc Health Risk Manag; 2015; 11():173-83. PubMed ID: 25767394
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases in acute coronary syndromes: current perspectives.
Kampoli AM; Tousoulis D; Papageorgiou N; Antoniades C; Androulakis E; Tsiamis E; Latsios G; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1192-205. PubMed ID: 22519449
[TBL] [Abstract][Full Text] [Related]
17. Gene silencing of TACE enhances plaque stability and improves vascular remodeling in a rabbit model of atherosclerosis.
Zhao X; Kong J; Zhao Y; Wang X; Bu P; Zhang C; Zhang Y
Sci Rep; 2015 Dec; 5():17939. PubMed ID: 26655882
[TBL] [Abstract][Full Text] [Related]
18. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques.
Lenglet S; Thomas A; Chaurand P; Galan K; Mach F; Montecucco F
Thromb Haemost; 2012 Mar; 107(3):409-16. PubMed ID: 22274652
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
[TBL] [Abstract][Full Text] [Related]
20. Vascular Smooth Muscle Cells Contribute to Atherosclerosis Immunity.
Hu D; Yin C; Luo S; Habenicht AJR; Mohanta SK
Front Immunol; 2019; 10():1101. PubMed ID: 31164888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]